#MSD Philippines

[srmprpickups]

Original article submitted:

“Let’s stop spreading fake news.”

This is the appeal of the panel of doctors and specialists who spearheaded the freshly held health talk on cervical cancer titled #TimeToTalkAboutHPV: A health forum on HPV prevention and cancer control. Organised by the Cervical Cancer Prevention Network of the Philippines (CECAP), together with the Asia & Oceania Federation of Obstetrics & Gynecology (AOFOG), the Philippine Obstetrical and Gynecological Society (POGS), and MSD in the Philippines, the media forum aims to serve as a reminder that cervical cancer is preventable with regular screening tests and the HPV vaccination.

“We should stop spreading wrong information that cervical cancer immediately means a death sentence. We must stop encouraging wrong beliefs about the disease, screening and the vaccine,” patient advocate Carmen Auste appealed to the media.

Cervical cancer is largely preventable through both vaccination and screening for precursor lesions (pap smear at least every three years and HPV DNA testing for women starting age 30), with appropriate follow up and treatment. With access to accurate information, preventive services, and routine gynecological care, most cases of the disease can be prevented and successfully treated at an early stage.

In spite of this, cervical cancer ranks as the 2nd most frequent cancer among women in Philippines and the 2nd most frequent cancer among women between 15 and 44 years of age. Current estimates indicate that every year 7,897 women are diagnosed with cervical cancer and 4,052 die from the disease.

Cervical cancer develops at the entrance to the uterus from the vagina and around 99 percent of the cases are linked to HPV or human papillomaviruses. Modes of transmission include sexual contact, skin-to-skin contact and rarely, through objects exposed to the virus. 

It’s a highly-treatable disease if detected at its early stages. The precancerous stage provides ample window for detection and treatment, and it could take as long as 30 years before it reaches malignancy.  However, it is one of the most common type of cancers and common cause of cancer-related deaths worldwide, affecting mostly young, uneducated women from poor countries. 

But more recently, COVID-19 has taken a toll on women’s health as studies have shown a gap in missed routine preventative exams and screening visits. “I think the world has been focused on Covid for the past 2 ½ years and we have overlooked other health concerns,” said Dr. Anna Lisa Ong-Lim, professor and chief of division of infectious and tropical disease in Pediatrics University of UP Manila College of Medicine. “It is only recently when vulnerabilities to vaccine-preventable diseases are being noticed once again.”     

Things you need to know about HPV

One life-altering issue that deserves focus is the huge burden that continues to threaten women and men, including teenagers worldwide, caused by the human papillomavirus (HPV). “HPV is a virus that causes a wide-range of diseases,” said MSD executive director of medical affairs for vaccines and infectious disease Dr. Mel Kohn.

“Apart from cervical cancer, the 2nd leading cancer for Filipinas, HPV can give men head and neck cancer, anal cancer for both sexes and a variety of less common but also devastating kinds of cancers,” he enumerated. Examples are vaginal and vulvar cancers, and penile cancer.

“Genital warts, while it doesn’t kill you, can be quite devastating,” interjected Dr. Kohn. “It is quite common and very difficult to eradicate. Imagine the psychological toll on the patient. Again, prevention is the best approach here.”

HPV is common. It is passed from one person to another during sexual contact. “It’s a quiet epidemic unlike COVID,” he warned. Unlike the measles that have obvious expression, “you don’t immediately see it when you meet somebody but it’s there and has been growing rather insidiously.”

The Philippines has a population of 37.8 million women ages 15 years and older who are at risk of developing cervical cancer. About 2.9% of women in the general population are estimated to harbor cervical HPV-16/18 infection at a given time, and 58.6% of invasive cervical cancers are attributed to HPVs 16 or 18.

Although some of the infections from this commonly occurring virus with more than 100 types usually go away on their own, at least 14 types of HPV have been found to be cancer-causing.

The age indication for HPV vaccines is as young as nine years old to both girls and boys. Teens and young adults through age 26 years who didn’t start or finish the HPV vaccine series also should have HPV vaccination. Women up to age 45 may be eligible for vaccination after discussing with their provider.

According to Dr. Ong-Lim, they are targeting the young ones because of their increased susceptibility to infections.

“That particular age group demonstrates optimal immune response. Also, only two doses are needed to achieve protection,” she shared.

But more importantly, giving the vaccine at a younger age ensures that they are already protected before they become sexually active. “HPV vaccines work best when given before exposure to the virus. We must try to catch that window when the immune system really responds very well to it,” explains Dr. Ong-Lim

Manila Declaration: Call to Action Against Cervical Cancer chair and practicing OP-Gynecologist Dr. Jean AnneToral mentions that the young and adult fertility study done recently, indicates that the average age Filipina women become sexually active is 18.2 years old. “Giving the vaccine at age 9-15 would be beneficial as there is no life event that exactly pinpoints exposure to HPV apart from age of sexual debut,” she said.

There will be seven to eight out of 10 women who would be exposed to HPV at one point in their life, “But not all women will develop cervical cancer,” assures Dr. Toral. The probability of HPV exposure developing into cancer increases if a patient smokes, is exposed to other sexually-transmitted diseases and has HIV.

School-based HPV vaccination

As part of the government’s effort to protect children and adolescents from vaccine-preventable diseases, the Department of Health together with partner agencies, rolls out the School-Based Immunization (SBI) Program.

The SBI Program includes measles, rubella, tetanus, diphtheria (MR-TD) and human papillomavirus (HPV) vaccines that are administered to eligible students in public elementary schools. The inclusion of HPV vaccination in the SBI Program aims to protect young women from cervical cancer later in life, among other diseases associated with HPV.

Under the DOH’s SBI Program, HPV vaccination is given to grade 4 based on DOH’s recommended age group to receive the two doses of HPV vaccine, six months apart, for protection against cervical cancer.

Prior to administering the vaccine, parents’ consent must first be obtained by school officials. That is why vaccination education campaigns usually highlight the role of parents in fortifying the health shield of their children through timely vaccination against diseases.

Due to the COVID-19 pandemic, the HPV vaccination, which was formerly delivered through the SBI Program is now being shifted as part of the Community-based Immunization to be able to still deliver HPV vaccination to young girls amidst the pandemic to protect them against cervical cancer and other HPV-related diseases and cancers.

Towards a cervical cancer-free future

The elimination of cervical cancer has been defined as achieving an incidence rate low enough for the disease to be considered controlled as a public-health problem; this threshold has been defined by the WHO as fewer than 4 cases per 100,000 women per year.

To accomplish this, every country must reach and maintain three key targets, within the lifetime of today’s young generation. The first is for 90 per cent of girls to be fully vaccinated against the human papillomavirus (HPV) by the age of 15. The second is to ensure that 70 per cent of women are screened using a high-performance test by the age of 35, and again by age 45. The final target is for 90 per cent of women with pre-cancer to receive treatment and for 90 per cent of women with invasive cancer to have their condition properly managed.

Achieving this vision and each of the elimination targets will require a whole-of-society and multisectoral approach to ensure health systems prioritize women and girls. Individuals, families, communities, , civil society, and government agencies at all levels have a role to play in championing greater awareness, education, and social support.

Auste said that the Philippines is among the countries that declared commitment together with WHO to finally eradicate cervical cancer in the country by 2040, and by 2030 worldwide. “There is already one type of cancer that we can delete or ‘block’ like social media,” she humored. “To attain that goal, we must augment HPV vaccine uptake and educate the Filipinos on HPV, vaccines and cancers caused by HPV,” she said.

Auste mentioned SUCCESS ('Scale-up Cervical Cancer Elimination with Secondary prevention Strategy') project as one of the advocacies recently launched in selected barangays. Led by Expertise France and delivered in collaboration with Jhpiego and Union for International Cancer Control (UICC) in support of WHO, the project aims to deploy innovative solutions to fight cervical cancer in four countries, including the Philippines.

At this critical juncture, we must empower women and rally our neighbors, community leaders, and governments to take action and save thousands of lives. If widespread, high coverage of these interventions can be achieved by 2030 and maintained, research predicts cervical cancer can be eliminated in most countries globally by 2120—avoiding over 63 million deaths of women globally.

Together, let’s commit to women everywhere to end cervical cancer. ###

[janetushar1]

Alcohol and Starch Enzyme Market to Hit $3962.3 Billion by 2032

The global Alcohol and Starch Enzyme Market was valued at USD 2549.8 Billion in 2024 and it is estimated to garner USD 3962.3 Billion by 2032 with a registered CAGR of 6.5% during the forecast period 2024 to 2032.

Global Alcohol and Starch Enzyme Market Research Report 2024, Growth Rate, Market Segmentation, Alcohol and Starch Enzyme Market. It affords qualitative and quantitative insights in phrases of market size, destiny trends, and nearby outlook Alcohol and Starch Enzyme Market. Contemporary possibilities projected to influence the destiny capability of the market are analyzed in the report. Additionally, the document affords special insights into the opposition in particular industries and diverse businesses. This document in addition examines and evaluates the contemporary outlook for the ever-evolving commercial enterprise area and the prevailing and future outcomes of the market.

Get Sample Copy of Report @ https://www.vantagemarketresearch.com/alcohol-and-starch-enzyme-market-1058/request-sample

** Note: You Must Use A Corporate Email Address OR Business Details.

The Major Players Profiled in the Market Report are:-

Advanced Enzyme Technology Ltd., ABF PLC, Codexis Inc., Amano Enzyme Inc., Dyadic International Inc., Dupont DE Nemours and Co. MSDS., Roquette Freres, Lesaffre, NovozymesA/S, The Soufflet Group

Alcohol and Starch Enzyme Market 2024 covers powerful research on global industry size, share, and growth which will allow clients to view possible requirements and forecasts. Opportunities and drivers are assembled after in-depth research by the expertise of the construction robot market. The Alcohol and Starch Enzyme Market report provides an analysis of future development strategies, key players, competitive potential, and key challenges in the industry.

Global Alcohol and Starch Enzyme Market Report 2024 reveals all critical factors related to diverse boom factors inclusive of contemporary trends and traits withinside the worldwide enterprise. It affords a complete review of the top manufacturers, present-day enterprise status, boom sectors, and commercial enterprise improvement plans for the destiny scope.

The Alcohol and Starch Enzyme Market document objectives to offer nearby improvement to the market using elements inclusive of income revenue, destiny market boom rate. It gives special observation and analysis of key aspects with quite a few studies strategies consisting of frenzy and pestle evaluation, highlighting present-day market conditions. to be. Additionally, the document affords insightful records approximately the destiny techniques and opportunities of worldwide players.

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/alcohol-and-starch-enzyme-market-1058/0

Global Alcohol and Starch Enzyme Market, By Region

1) North America- (United States, Canada, Mexico, Cuba, Guatemala, Panama, Barbados, and many others)

2) Europe- (Germany, France, UK, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, and many others)

3) the Asia Pacific- (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam, and many others)

4) the Middle East & Africa- (Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria, and many others)

5) Latin America- (Brazil, Argentina, Colombia, Chile, Peru, and many others)

This Alcohol and Starch Enzyme Market Research/analysis Report Contains Answers to your following Questions

What trends, challenges, and barriers will impact the development and sizing of the global market?

What is the Alcohol and Starch Enzyme Market growth accelerator during the forecast period?

SWOT Analysis of key players along with its profile and Porter’s five forces analysis to supplement the same.

How much is the Alcohol and Starch Enzyme Market industry worth in 2019? and estimated size by 2024?

How large is the Alcohol and Starch Enzyme Market? How long will it keep growing and at what rate?

Which section or location will force the market and why?

What is the important thing current tendencies witnessed in the Alcohol and Starch Enzyme Market?

Who are the top players in the market?

What and How many patents are filed by the leading players?

What is our Offering for a bright industry future?

The Research Objectives of this Report are to:-

Company, key regions/countries, merchandise and applications, historical records from 2018 to 2022, and global Alcohol and Starch Enzyme Market till 2032. Study and analyze the market length (cost and volume).

To recognize the structure of Alcohol and Starch Enzyme Market via way of means of figuring out its numerous subsegments.

Alcohol and Starch Enzyme Market on the subject of the primary regions (with every essential country). Predict the cost and length of submarkets.

To examine the Alcohol and Starch Enzyme Markets with appreciation to person boom trends, destiny prospects, and their contribution to the general market.

To examine aggressive trends consisting of expansions, contracts, new product launches, and acquisitions withinside the market.

Strategic profiling of key gamers and complete evaluation of growth strategies.

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/alcohol-and-starch-enzyme-market-1058

Reasons to Buy Market Report

The market record presents a qualitative and quantitative analysis of the market based on segmentation that includes each economic and non-economic element.

Alcohol and Starch Enzyme Market through the region. The market evaluation highlights the consumption of products/services in areas and well-known shows elements influencing the market in every region.

Alcohol and Starch Enzyme Market. It consists of an in-depth analysis of the market from specific views via Market Porter's Five Forces Analysis and provides insights into the market via the Value Chain.

The Alcohol and Starch Enzyme Market file provides an outline of market fee (USD) information for every segment and sub-segment.

It consists of an in-depth analysis of the market from distinct views via a 5 forces analysis of the Alcohol and Starch Enzyme Market and offers insights into the market through the fee chain.

Check Out More Reports

Global Electric Toothbrush Market:  Report Forecast by 2032

Global Vantage Market Research: Report Forecast by 2032

Global Mammography Market: Report Forecast by 2032

Global Automotive Artificial Intelligence Market: Report Forecast by 2032

Global Flat Steel Market: Report Forecast by 2032

[nexonmarketinsights12]

Medication Market Market Insights: Evaluating Growth Opportunities till 2032

New Research Report on “Medication Market Market” provide insightful data on the main market segments, dynamics, growth potentials and future prospects of industry. The study covers complete analysis on changing market trends for industry. The report shows the year-on-year growth of each segment and touches upon the different factors that are likely to impact the growth of each market segment. Each segment has analyzed completely on the basis of its production, consumption as well as revenue. And also offers Medication Market market size and share of each separate segment in the industry.

Get a Sample Copy of the Report at - https://www.proficientmarketinsights.com/enquiry/request-sample/1487

The global Medication Market size was USD 1548750 million in 2024 and the market is projected to touch USD 2179243.5 million by 2031, exhibiting a CAGR of 5.0% during the forecast period.

Top Key Players in the Medication Market Market:

Pfizer (U.S)

Roche (Switzerland)

Sanofi (France)

Johnson & Johnson (U.S)

Merck & Co. (MSD) (Germany)

Novartis (Switzerland)

AbbVie (U.S)

Gilead Sciences (U.S)

GlaxoSmithKline (GSK) (U.K)

Amgen (U.S)

AstraZeneca (U.K)

Bristol-Myers Squibb (U.S)

Eli Lilly (U.S)

Teva (Israel)

Bayer (Germany)

Novo Nordisk (Denmark)

Takeda (Japan)

Boehringer Ingelheim (Germany)

Request Sample for Covid-19 Impact Analysis - https://www.proficientmarketinsights.com/enquiry/request-covid19/1487

The Medication Market market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Market split by Type, can be divided into:

Brand Drugs

Generic Drug

Market split by Application, can be divided into:

Hospital

Clinic

Other

Report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our Medication Market market covers the following areas:

Medication Market market sizing

Medication Market market forecast

Medication Market market industry analysis

Inquire or Share Your Questions If Any Before the Purchasing This Report -https://www.proficientmarketinsights.com/enquiry/pre-order-enquiry/1487

What Global Medication Market Market Report Offers?

Provides strategic profiling of key players in the Medication Market market.

Drawing a competitive landscape for the world Medication Market industry.

Describes insights about factors affecting the Medication Market market growth.

Analyze the Medication Market industry share based on various factors- price analysis, supply chain analysis etc.

Extensive analysis of the industry structure along with Medication Market market forecast 2020-2024.

Granular Analysis with respect to the current Medication Market industry size and future perspective.

Regions Covered in Medication Market Market Report:

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

Purchase this Report (Price 2900 USD for a Single-User License) - https://www.proficientmarketinsights.com/purchase/1487

[rohans18]

Pleuritis Market Expected High Growth in Coming Years

Global Pleuritis Market, By Diagnostic Type (Thoracentesis, Imaging Devices, Blood Test, and Others), Treatment Type (Antibiotics, Antifungals, Blood Thinners, Nonsteroidal Anti-Inflammatory Drugs, and Others), End User (Hospital, Clinics, Diagnostics Laboratories, and Others), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

In the consistent Pleuritis market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Pleuritis industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Pleuritis market report brings precise and exact market research information that drives business into the right direction.

Key Players

The major players covered in the Pleuritis market are PharmJet, Taj Pharmaceutical Limited., Lupin, Merck Sharp & Dohme Corp., a subsidiary of MSD & Co., Inc.  Genentech, Inc., Aurobindo Pharma, Zydus Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Kadmon Pharmaceuticals, Schering Corp, Par Pharmaceutical. , THREE RIVERS PHARMACEUTICALS LLC , Valeant Pharmaceuticals, Teva Pharmaceuticals USA Inc, Sandoz Pharmaceuticals, Warrick Pharmaceuticals Corp, NAVINTA LLC.,>mcneilargusindia.com, AdvaCare Pharma, Leeford  and few others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. 

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-pleuritis-market

The research studies entailed in the winning Pleuritis market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Pleuritis Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

[alagonasleyyy]

Strategic Management Paper about Sevron Ltd.

I. EXECUTIVE SUMMARY

  Computer service software is widely recognized to be among the leading providers of OT solutions and outsourcing services in the Philippines. It is a centralized system within a company for tracking, prioritizing, managing, responding to, and resolving customer queries or employee requests all together. It can benefit companies of all sizes and types from multinational enterprises supporting millions of other businesses in multiple languages, to small consumer-facing businesses that need to answer customer questions quickly without hiring an army of support representatives.

          Sevron is one of the computer service support that has been using by many of the Filipinos and different people all over the world. It provides all companies with unique task-based risk assessment software provided through a web service. The company was created in year 2007 and now considered one of the most innovative online solution developers in the world. Constantly striving to reduce risk in the workplace, our intuitive solutions enable businesses of all sizes and sectors to create and manage Risk and COSHH assessments, acquire and manage Safety Data Sheets, and capture, record, and report workplace incidents in real-time. It has been created with the purpose of helping businesses reduce risk. To achieve that, they employ a holistic approach to what is a complicated problem. They do that by identifying the many different factors that contribute to risk; from obvious causes such as insufficient training and a lack of resources, to wider, more generalized problems, including the general misconception that health & safety is a hindrance to business. With all of these, Sevron becomes one the backbones of great customer experiences.  

II. INTERNAL ASSESSMENT

A. CORPORATE PROFILE:

Sevron provides all companies with unique task-based risk assessment software provided through a web service. The solution integrates a fully managed library of safety data sheets allows everyone to create a fully compliant task based COSHH risk assessment or task risk assessment within a minute from one simple and intuitive form. Sevron is used by over 40,000 users throughout the globe, and includes clients such as BHI Healthcare, Coca-Cola, Interserve, Virgin, Proctor and Gamble, and Weetabix. Joining Sevron Company can make your workplace a safer place to be.

 B. MISSION AND VISION

 The Mission

Our vision is for a noble cause that requires innovation to drive us towards our destination. Along the way we may have those who love us and those that do not but as long as our voices are heard, we will make a difference.

“To get where we are going, we need to have massive impact and take massive action.”

 The Vision

It is imperative that the negative social dogma surrounding Health and Safety be improved to protect our future generations.

Sevron have formed our volunteer community called The Knights of Safety™ to rebrand safety across our planet.

“The most important thing in safety since common sense.”

C. CORPORATE OFFICERS

They believe that to be successful the right people need to sit in the right seats and that’s exactly what their team is. Everybody has the ability to do the job but what matters most is that their team member meets their culture values. Each Sevronian might be an individual but together they work like a well-oiled machine, reaching goals fast and effective.

D. PRODUCT LINE

Computer / Software 

They make risk assessment, incident reporting and msds management apps, connected on one platform. Their mission is to protect you and your reputation. 

E. INTERNAL FACTOR EVALUATION MATRIX

The cumulative weighted score of the strengths is 2.06, while the weaknesses are 0.27, according to the table above from IFE Matrix. This demonstrates that the business has a large network of branches as well as a good working relationship with its employees. The number of experienced management teams with a positive value system and strong brand recognition had increased. Sevron has a strong internal role, as this graph indicates. Poor Service is Sevron's greatest internal flaw. This condition can be resolved by enhancing their facilities and properly training themselves to provide the best possible service to their customers.

III. EXTERNAL ASSESSMENT

A. PORTER’S MODEL ANALYSIS

Porter’s five forces

Porter’s five strengths show is a layout for any industry analysis that's utilized in analyzing an industry. The five competitive strengths are; dangers of modern participants, haggling control of clients, risk of substitute items, haggling control of providers and competitive rivalry within an industry. By applying Michael Porter’s five forces system, it'll offer assistance to establish Sevron Ltd.’s position within the market.

 Threats of new entrants

Sevron Ltd which is a universal computer software is competing with the Sphera, RAMs, Crams The one who supplied on the computer software developer are the Investors, manufacturers and clients the Sevron ltd is now considered one of the country’s most innovative online solution developers.

Bargaining power of suppliers

The control of providers in any given industry will ordinarily be decided by the sum of suppliers within the given industry. This implies that few suppliers in any industry will infer that the suppliers have more bargaining control. The suppliers for Sevron Ltd are Risk Assessment Software, COSHH Management Software and Incident Management Solution. These softwares developer companies have different features compared to universal softwares. These are being created with the purpose of helping businesses reduce risk such as insufficient training and a lack of resources, to wider, more generalized problems, including the general misconception that health & safety is a hindrance to business.

Bargaining power of buyers

The large array of safety data sheets has created a lot of power at the hands of the consumers. They use this system for their COSHH assessments, from start to finish they use a plethora of MSDS available to use which then self-populate all the hazardous you need to address. Once the initial purchase has been made, brand loyalty may start to formulate.

 Threats of substitute products

A substitute item can be portrayed as a software that's interesting whereas compared to another software within the system but can meet the needs more often than not by the software that it is different with. A few of the substitutes are Risk Assessment Software, COSHH Management Software. However, substitute threats cannot be said to be very high since they cannot be used in urgent cases unlike Sevron Ltd.’s software.

Rivalry among existing competitors in the industry

Rivalry between competing firms in a given industry can be of distinctive types. Competing firms compete in forms of cost wars, software differentiation and software development among others. Law entry boundaries within the industries implies that there exist many competitors within the different sectors that Sevron Ltd works in which results in intensified competition as the companies aim to extend their market share.

B. EXTERNAL FACTOR EVALUATION

Sevron Ltd., based on the External Factor Evaluation Matrix, has a weighted score of 2.15. Though, relatively lower on score than the average of 2.50, Sevron Ltd. still has influential significance and strength in its industry or the market. The low weighted score was highly influenced by the economic movements due to the COVID-19 pandemic, which is a primary variable.

According to the EFE Matrix, the factor with the most weight is the “Corporate Sponsorship”. This is due to the recent connections, partnerships, and sponsorships made by Sevron to other leading companies in the same and other industries. One of the biggest factors for these connections, partnerships, and sponsorships are their flagship product, COSHH365 Suite, which promotes chemical safety and protocols. On the other hand, the external factor with lowest weight is the “worker strikes”. Although it is not much imminent, the threat of worker strikes is still possible, thus still considered as an external threat factor in this matrix.

It is to be noted that Sevron Ltd.’s performance score shown in this EFE Matrix has significant difference from the results than their pre-pandemic performance. They are usually a high-performing and scoring company and could also be considered a primary competitor in the market. But due to the negative effects of the pandemic to the economy, their weighted score is also expected to be lower like this.

C. COMPETITIVE PROFILE MATRIX

The Critical Success Factors are vital for Sevron Safety Solutions Company’s Business Growth and opportunities. Though all play a crucial part for Sevron, ratings play an important role. Hence, these rankings range from 1-4. Four (4) being the highest and one (1) being the lowest in which they are vary based on the level of importance Sevron Safety Solutions Company prioritizes as follows:

4- means having superior importance

3- means having above average importance

2- means having average importance

1- Means having poor importance

According to the CPM matrix above, Sevron Safety Solutions obtained a total weighted score of 3.44. Sphera, on the other hand, obtained the highest total weighted score of 3.67 and CRAMs obtained a weighted score of 3.36.

In order to catch up in a few years, Sevron Company should focus on improving competitive advantage more and make substantial improvements with factors that have low ratings, allocating additional advertisements as well as investments.

   D. KEY EXTERNAL FACTORS

Key External Factors that Bring Opportunities for the Company

Corporate Sponsorship

Economic Status

Growth in Technology

Environment

Majestic Software Upgrade

Other Key External Factors that Bring Opportunities for the Company

Rising of Technological Dependence

Businesses strengthening their Internal Control Systems

Economic rebound to be expected

Key External Factors that Bring Threats for the Company

Increase of Dollar and Peso Difference

Business Tax Increases in the Country

COVID 19/Pandemic

National Disaster/Fortuitous Events

Worker Strikes

Other Key External Factors that Bring Threats for the Company

Big economic recession

Shortage for skillful employees

IV. STRATEGY FORMULATION

A.         BOSTON CONSULTING GROUP MATRIX

According to the matrix above, Forward and Horizontal Integration is a star category for Sevron Health & software because the company competes in a rapidly growing industry. Since 2017, Sevron has provided solutions such as risk management, safety data sheet inventory, and COSHH risk assessment management to their 7.7 million trusted users around the world.

Related diversification, market development, and penetration are in the question mark category because they have a large market share in a slow-growing industry, whereas product development and backward integration are in the cow category since they should be the company's priority to keep their powerful position for as long as possible. Sevron does not have services or strategies that fall under the dog category, since Sevron’s services are competitive.

 B.       STRATEGIC POSITION AND ACTION EVALUATION MATRIX

The SPACE matrix which is also known as the strategic position and action evaluation is a four-dimension framework that illustrates whether an organization’s strategies are forceful, conventional, defensive or competitive. The SPACE matrix normally has two axes where one axis represents the two internal dimensions of an organization – financial and competitive position while the other axis represents two external dimensions – stability and industry position.

A look at Sevron’s performance shows that the company should be placed on the aggressive quadrant since it is financially stable and competing very strongly in the various industries that it serves. Since Sevron qualifies to be on the aggressive

C.        GRAND STRATEGY MATRIX

Although Sevron Ltd.’s growth may be strong and large, but their competitive position is weakening and they are under threat of being pushed out of the market by other companies. They are not able to compete effectively. The market is growing fast and an intensive horizontal integration strategy helps. Also, the situation doesn’t help since pandemic really gave negative effects to the company and also to the economic.

D .      INTERNAL-EXTERNAL MATRIX

Based on the IFE and EFE Matrices in the previous factor evaluations, with the resultant result and scores were 2.33 and 2.97 respectively, the joint effect of the internal and external analysis falls in CELL V rates 2.97 for IFE Total Weighted Scores and CELL V that rates 2.33 for EFE Total Weighted Scores.

The outcome of the IFE and EFE total weighted scores falls and described as HOLD AND MAINTAIN strategies wherein this section shows that the company should focus on market penetration and product development. It should expand, but not aggressively; Penetrate market further; Develop new products or modify existing products.

 E.         STRENGHTS- WEAKNESSES- THREATS- ANALYSIS

Strengths

Software Services

One of the best in terms of     software services specially when it comes to health and safety software     developing.

Corporate Culture

Strong corporate culture and     ethics being promoted by the management inside the organization. Proof of     this is the “Top 10 Values of the Sevronians”.

Strong Brand Recognition

Sevron Ltd. is pretty much     well-known to big companies (Coca-Cola, AkzoNobel, EDF, etc.) and business     powerhouses as it is one of the top software developers and producers when     it comes to health and safety, which helps those businesses strengthen     their internal controls.

High Level of Customer Satisfaction

Sevron Ltd. receives a     strong 5-star recognition from its big company customers like Coca-Cola,     AkzoNobel, EDF, and GKN Aerospace showing that the products and service     are top-notch.

Service Time

As the software products are     already developed by the time the customers avail, there is no to less lag     time when it comes to service. Though if modifications were requested, the     time consumed before service is still considerably excellent.

Experienced Management Team

Management team of Sevron     Ltd. is composed of highly-trained professionals who are more than     qualified for their positions and with considerable number of years of     experience in the field and in the company.

 Weaknesses

Inaccessible to a Larger Consumer Audience

Sevron Ltd. is a very much     well-known software developer and service provider for big companies. But     its name is pretty much new for those small-time and start-up businesses.     Its main target of business is also mainly on western countries, leaving a     large consumer audience on the east unattended.

Lacks Other Product Segments

Sevron Ltd. is very much     successful when it comes to its core product or service. But it lacks     other known products or failed to introduce other products besides its     main product or service.

Ineffective Promotions and Advertisements

Even though Sevron Ltd. is     pretty well known to big companies, it is still a stranger for small-time     and upcoming businesses. There are also few advertisements being done,     denying to maximize the use of social media and new technologies.

Access to International Markets

Sevron Ltd. is a big company     but it still doesn’t have access to the majority of the world. 

Need for New and Flexible Product and Service

Sevron Ltd. is a leading     player in the industry it is in. But, as the demand for more new software     service and product rises from different business types, the company can’t     keep up as much. Though it introduces a new service (COSHH Risk Assessment     Management), it is pretty much specific. It is burdensome for small to     medium-time businesses. Thus, the need for more flexible product services     is needed.

 Opportunities

Corporate Sponsorship

Sevron Ltd. is being offered     and receiving partnerships and sponsorships from various companies from     other industries due to the demand of the health and safety software they     offer.

Economic Status

Global economy is starting     to recover after the economic crisis brought by COVID-19 pandemic.

Growth in Technology

Technological advancements     help Sevron Ltd. to produce and manufacture high-quality software products     and services. Newly introduced technologies also help to increase     efficiency and productivity for businesses.

Environment

Global movements encourage     businesses to make sustainable products and services opening opportunities     for Sevron Ltd. to cater a larger array of customers through sustainable     software designed to be used by businesses.

New Trends on Consumer Behavior

An opportunity to lure new     customers as the trend on consumer behaviors changes. 

 Threats

Increase of Dollar and Peso Difference

Foreign exchange rate     instability poses risks and threats for Sevron Ltd. in terms of global     market penetration and operations.

Business Tax Increases in the Country

Philippine’s corporate tax     is the highest among other Southeast Asian countries with 30% tax rate.     Although recently because of COVID-19, corporate taxes are reduced to 25%,     it is still substantial as the economy is still unstable thus this high     tax rate can pose a threat.

COVID 19/Pandemic

Businesses are highly     affected by the effects of COVID-19 in the economy. COVID-19 also affected     the Philippine economy the worst in Asia making it unideal for businesses     at the moment. 

National Disasters/Fortuitous Events

As fortuitous events mean,     this is unavoidable. Philippines as it is located in the Pacific Ring of     Fire is prone to natural disasters, from earthquakes to volcanic     eruptions, not to mention the frequent strong typhoons. 

Worker Strikes

Labour quality in the     Philippines can be deemed unideal. Low-income salary and wages, poor     employee treatment and protection by law, unideal work environments, and     such lead workers to rally or have worker strikes. Thus poses a threat for     businesses, especially with bigger multi-national businesses like Sevron     Ltd. 

F.         QUANTITATIVE STRATEGIES PLANNING MATRIX

In the QSPM table, two alternate strategies are the Market Penetration and Market Development. The Total Attractiveness Scores is 4.84 and 3.75. Sevron provides all businesses with task-based risk management software that is accessible through the internet. Since its inception, it has been very profitable and has been growing at a rapid pace. These strategies were developed, implemented, and evaluated in order to make functional decisions that would allow them to continue to meet their goals. Sevron has accumulated some of the methods that were developed and analyzed using an analysis of external and internal variables, multiple matrices, and SWOT Analysis. 

Market Penetration and Market Development on improving the goods and services are both bonded to all of the strategies that have been performed, according to the SWOT Study. The BCG Matrix was used to plot the market share and strategies for the company's products and services. The SPACE Matrix is a strategy formulation method that focuses on an organization's strategic position at the height of its business. The GSM is used to decide which technique is most appropriate. External and internal variables are used again to determine how appealing each strategy is. The GSM's findings indicate that market penetration and development are feasible.

 According to our findings, business development for enhancing operations and service, as well as market development, which includes service development, upgrading new services and product technology, and staff development training, must be introduced in order for Sevron Ltd to maintain its current market and industry position.

 V. STRATEGY RECOMMENDATION

It is recommended by any business company that they need to create an intensive strategy. These strategies are required to do for the goal, improvement or for the development of the company.

1. Software Improvement.

Sevron’s products are vulnerable to cybercrime. For example, the operating system remains a target of countless cybercrime attacks globally. This factor is a weakness because it limits the attractiveness of products. In this regard, cyber security is a product aspect of competition among firms in the computer hardware and software industry. On the other hand, the imitability of some products is a weakness because it could reduce the strength of the Sevron brand. Moreover, the company’s product portfolio shows dependence primarily on software products, which weakens the business against competitors that have dominant hardware and software products in the market.

 2. Product development 

A product can be described as anything that is capable of providing a solution to a customer’s perceived problem whether it is physical or psychological. Therefore, any product that fails to provide the needed solution to a customer is not a good product. 

 VI. ACTION PLAN

In order for the company to achieve its strategic objectives, action plans usually involve determining who will do what, by whom, and in what order. The structure and needs of the company influence how action planning is designed and implemented.

Market Penetration 

This intervention entails extending operating hours and days, promoting other business partnerships, and safeguarding clients' reputations. This will keep and serve more clients, and it would be more effective if more time management is followed.

 Market Development 

         A successful collaboration with a well-known company can be beneficial to Sevron Ltd.’s. company expansion. The aim of collaborating with businesses is to increase market share, benefit, and market expansion. Clients will be able to connect with the goods and services available as a result of this. Only through their partnerships will they raise brand and company recognition.

 VII. CONCLUSION

For the researchers’ final analysis, Sevron needs to focus on improving and implementing strategies specifically in market penetration and market development. These strategies were found based on the statistical outcomes of different matrices which are the IFE Matrix, EFE Matrix, CPM, BCG Matrix, SPACE Matrix, GSM, IE Matrix and QSPM. 

Based on the Internal Factor Evaluation Matrix (IFE Matrix), the Sevron Software Company has a total weighted score of 1.59 while the weakness is 1.02. It demonstrates the company’s extensive network of branches and a good working relationship with their employees and management teams. It only shows that the most significant internal flaw is poor service. This problem can only be resolved if they enhance their facilities and adequately train themselves to provide the best possible service to their customers and build their company’s integrity. While in the External Factor Evaluation (EFE Matrix), it has a weighted score of 2.15. Though relatively lower on the score than the average of 2.50, Sevron still has influential significance and strength in its industry or the market. The economic movements highly influenced the low weighted score due to the COVID-19 pandemic; they are usually a high-performing and scoring company and could also be considered a primary competitor in the market.

         In the Competitive Profile Matrix (CPM), Sevron only ranked second with a total weighted score of 3.44. While Sphera, their biggest competitor which ranked first with a total weighted score of 3.67, and on the other hand, Crams the last place with only a 3.36 weighted score. Being able to snatch first place from Sphera, the company should focus on improving competitive advantage and making substantial improvements with factors that have low ratings, allocating additional advertisements, and investments.          

         In the Boston Consulting Group Matrix (BCG Matrix), Forward and Horizontal Integration are the stars of Sevron Safety Solutions because the company competes in a rapidly growing industry. The company can provide a solution such as risk management, safety data sheet inventory, and COSHH risk assessment management to their 7.7 million trusted users worldwide. Related diversification, market development, and penetration were put in the question mark category because they have a significant market share in a slow-growing industry. In contrast, product development and backward integration are in the cow category since they should be the company's priority to keep their powerful position for as long as possible. They do not have services and strategies that fall under the dog category since the company is a competitive one.

         According to the Strategic Position and Action Matrix (SPACE Matrix), the company's performance shows that it should be placed on the aggressive quadrant since it is financially stable and competing very strongly in the various industries it serves. Since it qualifies to be on the aggressive side, it means that the company can fully exploit available opportunities and enhance its market share. As the company has the high financial strength, high industry strength, enjoys a competitive advantage, belongs to an attractive industry, and operates in relatively stable environmental conditions.    

         As what has been stated above and as the results of the matrices that are given, Sevron needs alternative strategies to fulfill their lack in terms of product, services, competitors, etc. and to be more successful in the industry. In addition, the Quantitative Strategic Planning Matrix (QSPM) shows the two alternative strategies: Market Development and Market Penetration. These two must be developed, implemented, and evaluated to make operational decisions that would allow them to continue meeting their goals. These strategies can help Sevron Software Services fulfill their lack of product, services, competitors, etc., and to be more thriving in the industry.

 VII. FINANCIAL PROJECTION

Based on the given tables above, which is the Income statement. Sevron Safety Solutions seems to be doing well in the computer software industry despite of major competitors such as Sphera, RAMs, CRAMS, and other Software vendor businesses. With this level of major competition, The Company managed to stay ahead of its game and compete with other competitors. Sevron is a well-known and a competitive software company that places itself as one of the leading companies in the computer software industry.

REFERENCES

Competitive Matrix References Adison. (2019). Marketing Mix Sun Life Financial Inc. Retrieved from https://www.essay48.com/term-paper/15481-Sun-Life-Financial-Inc-Marketing-Mix

David, F., & David, F. (2017). The External Audit. Strategic Management: A Competitive Advantage Approach, Concepts and Cases (16th ed.). Pearson.

David, F., & David, F. (2017). Strategy Generation and Selection. Strategic Management: A Competitive Advantage Approach, Concepts and Cases (16th ed. 258-262). Pearson.

Dale Allen. (2007). The Mission. Retrieved from https://www.sevron.co.uk/the-mission

Dale Allen. (2007). The Vision. Retrieved from https://www.sevron.co.uk/the-vision

Joyasaini. (2010). The SPACE matrix. Retrieved from Scribd: https://www.scribd.com/doc/41739334/The-SPACE-Matrix

Maxi-Pedia. (2017). IFE Matrix (Internal Factor Evaluation). Retrieved from http://www.maxi-pedia.com/ife+efe+matrix+internal+factor+evaluation

Maxi-Pedia. (2017). Quantitative Strategic Planning Matrix (QSPM). Retrieved from http://www.maxipedia.com/ife+efe+matrix+internal+factor+evaluation

Mcclure, B. (2020), How to Analyze a Company’s Financial Position. Retrieved from https://www.investopedia.com/articles/fundamental/04/063004.asp

Mulder, P. (2019). Grand Strategy Matrix. Retrieved from https://www.toolshero.com/strategy/grand-strategy-matrix/

Pbctoday. (2019). Sevron and BESA Partnership to Streamline Chemical Safety. Retrieved from https://www.pbctoday.co.uk/news/health-safety-news/streamlining-workplace-safety/67580/

Rajak. (2021). Internal External Matrix. Retrieved from          https://hmhub.me/internal-external-matrix/

Rocket reach. (2007). Sevron Information. Retrieved from https://rocketreach.co/sevron-profile_b5e2bcb9f42e634e

Rosette Dela Paz. (2011). The IFE Matrix/EFE Matrix. Retrieved from https://rossete-blog-blog.tumblr.com/post/3848879614/strama-paper-waterfront-hotel

Sevron. (2017). Safety365 Anniversary Update. Retrieved from Sevron:  https://www.sevron.co.uk/blog/safety365-anniversary-update

Sevron. (2019). Sevron’s AI Technology Provides Clear Insight. Retrieved from https://www.sevron.co.uk/blog/sevrons-ai-technology-provides-clear-insights

Trust Pilot. (2007). Sevron LTD. Retrieved from https://uk.trustpilot.com/review/www.sevron.co.uk

[pinoyscientists]

Meet Ronald Reyes, organic chemist

1) What do you do?

I have been working on the development of efficient strategies aimed towards the direct transformation and functionalization of C(sp3)–H bonds, an essential task that is considered as a long-standing challenge in synthetic chemistry. In particular, my work deals with the realization of a highly enantioselective transition-metal catalyzed borylation reaction of the ubiquitous C–H bonds in organic molecules to yield important synthetic intermediates that are useful for the preparation of compounds significant to the chemical, pharmaceutical, and agrochemical industries.

2) Where do you work?

I am presently a PhD student (graduating this September 2018) at the Hokkaido University in Sapporo City, Japan. I belong to the Organometallic Chemistry Laboratory of Professor Masaya Sawamura who was awarded recently with the prestigious Nagoya Medal of Organic Chemistry.

Before pursuing my PhD degree in Japan, I worked as an Assistant Professor at the De La Salle University, Manila (2014-2015) and as an Instructor at the Chemistry Department in the Ateneo de Manila University (2009-2014). I had also been given the opportunity to join the research group of Professor Koji Tanaka at the Institute for Molecular Science in Okazaki City, Japan (2011-2012).

3) Tell us about the photos.

[Left:] At the Annual Symposium of Organic Chemistry supported by the MSD Life Science Foundation, Japan. In this photo, I was explaining the significance and major results of my work during one of the poster sessions of the conference.

[Right - Photo 1:] This is winter wonderland in Hokkaido University! Every winter the school campus is transformed by the enigmatic non-stop downpour of white, succulent, stunning snow. Amidst the beauty is the challenge to go to the laboratory every day during the winter-- the struggle is real!

[Right - Photo 2:] At the International Food Festival held annually at Hokkaido University. This is one of those times when Filipino students of Hokkaido University (HAFS, Hokkaido University Association of Filipino Students) unite to bring our culture to the world. During this festival, we prepare Filipino food (adobo, buko pie, kwek-kwek, etc.) and sell them at affordable prices. We prepared Pinoy-style chicken barbeque along with banana-que. With me in this picture is Mr. Kevin Garas who is taking up his MS degree. This event is one sure way to let everyone know that it is indeed more fun in the Philippines!

4) Tell us about your academic career so far.

My fascination towards the sciences started during my high school days at Bacoor National High School – Annex. I graduated high school with an intense desire to study chemistry. I got the inspiration from my science teachers especially my chemistry teacher, Mrs. Dorado. 

I pursued my BS Chemistry degree at the University of the Philippines-Diliman. My undergraduate research work under the supervision of Dr. Florentino Sumera deals with the characterization of the curing kinetics of an epoxy-amine system liquid underfill encapsulant material by differential scanning calorimetry. 

I decided to pursue my graduate studies at the Ateneo de Manila University where I obtained my MS Chemistry degree. During my stay in the Ateneo, I worked with the synthesis and characterization of some of the biomimetic complexes of Manganese, Cobalt and Ruthenium. I have accomplished this under the guidance of Dr. Armando Guidote Jr. as well as through the supervision of Professor Koji Tanaka of the Institute for Molecular Science in Okazaki City, Japan. I worked as an Instructor at the Chemistry Department of the Ateneo de Manila University while taking up my Master’s degree.

After this, I was given the chance to join the Chemistry Department of the De La Salle University, Manila. I started as an Associate Professorial Lecturer and eventually as an Assistant Professor before I pursue my PhD studies in 2015. I will graduate this September 2018. I plan to continue my career in the academe because I love teaching and research.

5) Anything else you’d like to share.

To anyone reading this, join me in encouraging more of our younger generation to consider the path less travelled, the path of becoming a Pinoy Scientist. We, Filipinos, have so much to share and offer to our country and the world. While we still strive to be a global leader in the sciences, I believe that Pinoy scientists have already contributed so much to the advancement and creation of scientific knowledge worldwide.

When I was a kid, my simple observation of how my father will boil water in our old aluminum pot ignited my interest to study more about the reasons for such simple bubbling and evaporation. What I am trying to say is that there is a scientist in all of us. We just need to nurture our curiosities and aim to help advance our country-- through our little but meaningful contribution. It is a long way to go, but with the talents of Filipinos, we will surely one day achieve this elusive dream.

Just like in chemistry, we all should maximize bonding, break the barrier, and spark the change!

[srmprpickups]

Original article submitted:

The implications of COVID-19 on the global healthcare sector are immense. People are devouring all available information and realigning household expenses to protect themselves from the disease. With much attention devoted to fighting the virus, many tend to forget that there are other deadly diseases that also deserve equal, if not greater, consideration.

One of the killer diseases that was severely impacted is cancer. The World Health Organization reported that prevention and treatment of non communicable diseases (NCDs) like cancer have been severely disrupted globally. [1] Cancer-related services provided by different countries have been partially, if not completely, disrupted.[2]

MSD in the Philippines, through its cancer advocacy campaign Hope From Within (HFW), is taking an initiative to remind the public that cancer does not sleep during these challenging times. 

“Cancer remains as one of the greatest healthcare challenges for Filipinos, with its prevalence continuing to increase each year, hence cancer care, most importantly access to quality cancer care should continue to be prioritized,” said (spokesperson).

Tita Hope Talks

If anything, the pandemic has further emphasized the seriousness of cancer because some types of cancers increase a patient’s risk of severe illness and prolonged infection from COVID-19. Those who had recently received treatments are also highly vulnerable to the virus because of weakened immunity.

To help bridge the gap caused by disruption in health services related to cancer, HFW is conducting a series of Cancer Care Access dialogues called Tita Hope Talks. HFW ambassador and broadcast journalist Nina Corpuz, aka TIta Hope, will serve as moderator as key opinion leaders from various sectors share their insights on how to improve cancer care delivery to Filipino patients and their families, and to help them navigate their cancer journey even during the pandemic.

This simplified discussions on cancer will also provide insights on access to quality cancer care, and ways to provide quality of life to and improve overall survival of cancer patients.

There will be four talks scheduled for the entire year; the first symposium will happen on the 19th of May and will focus on access to information on the disease.

Cancer Survey

MSD Philippines commissioned IQVIA, which provides support services for pharmaceutical, biotech and medical companies, to conduct an online survey that measures the Filipinos’ level of understanding on the disease - including attitudes towards testing, treatment and access. A total of 1,000 participants from different age groups representing various socio-economic levels and regions responded to the survey.

The study revealed that 2 out of 5 Filipinos have personal experiences with cancer either as patients or through family, friends or colleagues diagnosed with the disease. The magnitude of the disease highlights the importance of sharing responsibility between the government and the entire health stakeholder community in carrying the burden of cancer.   

The Cancer Survey can be used at national level to monitor awareness over time, compare awareness and attitudes between groups, identify information needs, and monitor the impact of awareness-raising interventions.

IQVIA Asia Pacific general manager for Philippines Mylene Rodriguez will discuss the results and its significance to drafting national and local health policies as one of the speakers in the first Tita Hope Talks.

Financial burdens of cancer

Cancer is an expensive disease. Some families just cannot afford the high levels of out-of-pocket expenditures.

Creating a financial plan may help reduce stress and unnecessary expenditures. Patients and carers are advised early on to gather necessary and helpful information on medical and financial access options. In the Philippines, patients can seek assistance from various government agencies, charity organisations and social programs such as Philippine Charity Sweepstakes Office (PCSO),PhilHealth and Malasakit Program.

The overwhelming costs associated with cancer as well as recommended funding sources will be tackled by UP-PGH director Gerardo Legaspi.

Cancer Game Plan Report

The enactment of landmark legislation National Integrated Cancer Control Act (NICCA) is a game changer for Filipino cancer patients and families. Key provisions under the law include the creation of Philippine Cancer Center, a Cancer Assistance Fund and the National Integrated Cancer Control Council, in charge of policy making, planning and coordinating body on cancer control, headed by the Secretary of Health.   

The act addresses gaps in cancer care including access to affordable cancer treatments. There is now a wider range of treatment options available as indicated in the Cancer Game Plan Report, a health impact projection model or research that uses local data sets to project cancer outcomes and reveal potential benefits of innovative treatment options.

Commissioned by MSD Philippines in partnership with Dra. Madeleine Valera, MD, MScIH and former Undersecretary of Health, and medical oncologist Dr. Gerardo Cornelio of St. Luke’s Medical Center, the report indicates that innovative treatments such as immunotherapy is expected to bring new hope for select cancer patients as it can help them to further enjoy added years to their life, progression-free life years, quality-adjusted life years, and overall improved health gains between five- and ten-fold.

The funding support included in the provisions of NICCA is crucial to enabling accessibility to innovative treatment options that may be costly.

Dr. Valera herself will discuss this vital aspect of cancer care along with Philippine Society of Medical Oncology president Dr. Bill Ramos, who will share the group’s position on the proper funding and implementation of the National Integrated Cancer.

Sharing the cancer journey

HFW ambassador and veteran actress Susan Africa also joins the Tita Hope Talks panel to discuss her personal journey as a cancer carer for her late husband Spanky Manikan. 

Carers play a critical role in the healing journey of a patient. Although their journey may be different from that of a patient, it is still fraught with challenges. It can be a financially, emotionally and mentally taxing job; and those who have personally experienced this duty are the best source of information as well as inspiration to those who are treading the same path.

While the country has achieved great strides in battling cancer, there are still areas that could benefit from further development. Cancer remains as one of the leading causes of mortality in the country, and this continuously growing epidemic necessitates sustained campaigns that help ease cancer burden among Filipinos.

Advocacy campaigns such as MSD’s HFW seeks to expand accessibility  to more treatment options and quality cancer care for all Filipinos across class segments through provision of information and calls for increased multi-sectoral support including implementation and funding from NICCA.

To know more about Tita Hope Talks , you may visit Hope From Within website at https://hopefromwithin.org/, and their official Facebook page at https://www.facebook.com/Hopefromwithinph. ###

[1] COVID-19 significantly impacts health services for noncommunicable diseases. June 1, 2020. https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases.

[2] Impact of COVID-19 on cancer care has been ‘profound’, warns UN health agency. February 2, 2021. https://news.un.org/en/story/2021/02/1083552.

[freefestwinner]

Global Dog Prescription Drugs Market Overview, Size, Share and Trends 2025

Summary - A new market study, titled “Global Dog Prescription Drugs Market Insights, Forecast to 2025” has been featured on Wise Guy Reports.

Dog prescription drug is a kind of animal prescription. Animal prescription drug is a prescription drug used to prevent, treat, diagnose, or purposefully regulate an animal's physiology. Animal prescription drugs mainly include: serum products, vaccines, diagnostic products, micro-ecological products, chemicals, antibiotics, biochemical drugs, radioactive drugs and external insecticides, disinfectants, etc.

ALSO READ: https://icrowdnewswire.com/2019/10/18/dog-prescription-drugs-market-2019-global-analysis-forecast-to-2025-market-research-report/

The global Dog Prescription Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dog Prescription Drugs market based on company, product type, end user and key regions.

 This report studies the global market size of Dog Prescription Drugs in key regions like North America, Europe, China and Japan, focuses on the consumption of Dog Prescription Drugs in these regions.

This research report categorizes the global Dog Prescription Drugs market by top players/brands, region, type and end user. This report also studies the global Dog Prescription Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

 The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Elanco Animal Health

Ceva Sante Animale

MSD Animal Health

Zoetis

Virbac

Dechra

Vetoquinol

Animalcare Group

Ourofino Saude Animal

Boehringer Ingelheim

 Dog Prescription Drugs market size by Type

Oral Type

Smear Type

Injection Type

Spray Type

 Dog Prescription Drugs market size by Applications

Hospital

Clinic

Others

 Market size by Region

North America

United States

Canada

Mexico

Europe

Germany

France

UK

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Central & South America

Brazil

Middle East & Africa

Turkey

GCC Countries

Egypt

South Africa

 The study objectives of this report are:

To study and analyze the global Dog Prescription Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

To understand the structure of Dog Prescription Drugs market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Dog Prescription Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Dog Prescription Drugs submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

 In this study, the years considered to estimate the market size of Dog Prescription Drugs are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dog Prescription Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

FOR MORE DETAILS: https://www.wiseguyreports.com/reports/4451871-global-dog-prescription-drugs-market-insights-forecast-to-2025

About Us: Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.  

 Contact Us:

NORAH TRENT                                                    

sales@wiseguyreports.com      

Ph: +162-825-80070 (US)                          

Ph: +44 203 500 2763 (UK)      

[rohans18]

Niemann-Pick Market Key Players, Outlook and Forecast 2028

Global Niemann-Pick Market, By Disease Type (Type A, Type B, Type C and Type E), Diagnosis (Physical Examination, Skin Biopsy, Biochemical Testing, Genetic Testing), Treatment (Miglustat, Physical Therapy and Others), Age Group (Perinatal, Early Infantile, Late Infantile, Adult) End-Users (Clinics, Hospitals, Diagnostic Centers, Others), Distribution Channel (Direct Tenders, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

In the consistent Niemann-Pick market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Niemann-Pick industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Niemann-Pick market report brings precise and exact market research information that drives business into the right direction.

Key Players

The major players covered in the Niemann-Pick market are PharmJet, Taj Pharmaceutical Limited., Lupin, Merck Sharp & Dohme Corp., a subsidiary of MSD & Co., Inc.  Genentech, Inc., Aurobindo Pharma, Zydus Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Kadmon Pharmaceuticals, Schering Corp, Par Pharmaceutical. , THREE RIVERS PHARMACEUTICALS LLC , Valeant Pharmaceuticals, Teva Pharmaceuticals USA Inc, Sandoz Pharmaceuticals, Warrick Pharmaceuticals Corp, NAVINTA LLC.,>mcneilargusindia.com, AdvaCare Pharma, Leeford  and few others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. 

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-niemann-pick-market

The research studies entailed in the winning Niemann-Pick market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Niemann-Pick Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

[jacobwill176]

Global Dog Prescription Drugs Market  Size, Share, Development and Forecast Overview forecast year 2020

A new market study, titled “Global Dog Prescription Drugs Market Insights, Forecast to 2025frastructur” has been featured on …

October 05, 2020                                

Dog prescription drug is a kind of animal prescription. Animal prescription drug is a prescription drug used to prevent, treat, diagnose, or purposefully regulate an animal's physiology. Animal prescription drugs mainly include: serum products, vaccines, diagnostic products, micro-ecological products, chemicals, antibiotics, biochemical drugs, radioactive drugs and external insecticides, disinfectants, etc.

The global Dog Prescription Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dog Prescription Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Dog Prescription Drugs in key regions like North America, Europe, China and Japan, focuses on the consumption of Dog Prescription Drugs in these regions.

This research report categorizes the global Dog Prescription Drugs market by top players/brands, region, type and end user. This report also studies the global Dog Prescription Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Elanco Animal Health

Ceva Sante Animale

MSD Animal Health

Zoetis

Virbac

Dechra

Vetoquinol

Animalcare Group

Ourofino Saude Animal

Boehringer Ingelheim

Dog Prescription Drugs market size by Type

Oral Type

Smear Type

Injection Type

Spray Type

Dog Prescription Drugs market size by Applications

Hospital

Clinic

Others

ALSO READ : https://icrowdnewswire.com/2019/10/18/dog-prescription-drugs-market-2019-global-analysis-forecast-to-2025-market-research-report/

Market size by Region

North America

United States

Canada

Mexico

Europe

Germany

France

UK

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Central & South America

Brazil

Middle East & Africa

Turkey

GCC Countries

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Dog Prescription Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

To understand the structure of Dog Prescription Drugs market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Dog Prescription Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Dog Prescription Drugs submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Dog Prescription Drugs are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dog Prescription Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

FOR MORE DETAILS : https://www.wiseguyreports.com/reports/4451871-global-dog-prescription-drugs-market-insights-forecast-to-2025

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.  

Contact Us:

NORAH TRENT                                                      

sales@wiseguyreports.com      

Ph: +162-825-80070 (US)                        

Ph: +44 203 500 2763 (UK)    

[phgq]

PENRO-Cavite leads clean-up drive in protected area on World Wildlife Day 

#PHinfo: PENRO-Cavite leads clean-up drive in protected area on World Wildlife Day 

TRECE MARTIRES CITY, Cavite Mar. 9 (PIA) --The Cavite Provincial Environment and Natural Resources Office (PENRO) in cooperation with the local government of Ternate organized a clean-up activity along the roadside of Mounts Palay-Palay-Mataas-na-Gulod Protected Landscape on March 3, 2021.

The activity was held in observance of the World Wildlife Day with this year's theme: "Forest and Livelihood: Sustaining People and Planet" which aimed to clean the road in the protected area, a wildlife habitat, with approximately 5km from Puerto Azul.

PENRO Head Ronita A. Unlayao together with MSD Chief Susan L. del Rosario and TSD Reynaldo A. Belen led the clean up activity.

Unlayao stressed that illegal waste dumping and littering are prohibited under RA 9003, also known as the "Ecological Solid Waste Management Act 2020."

"We need to continuously educate the public to avoid littering especially when entering a biodiversity-rich area and to always practice waste segregation where we are," Unlayao said.

Coinciding with PENRO's National Women's Month celebration with this year's theme, "Women Can Make Change Amidst Climate Crisis and CoViD-19," all women employees of the office participated in the clean-up activity, all dressed in purple shirt to honor the extraordinary role of women in society as leaders and forerunners of change.

About 69 sacks of non-biodegradable wastes composed of PET bottles, plastic wrappers, and facemasks were collected during the clean-up that were hauled by the Ternate Municipal Garbage Collector. (Ruel Francisco with reports from Dennis Abrina) 

***

References:

* Philippine Information Agency. "PENRO-Cavite leads clean-up drive in protected area on World Wildlife Day ." Philippine Information Agency. https://pia.gov.ph/news/articles/1068630 (accessed March 09, 2021 at 03:20PM UTC+08).

* Philippine Infornation Agency. "PENRO-Cavite leads clean-up drive in protected area on World Wildlife Day ." Archive Today. https://archive.ph/?run=1&url=https://pia.gov.ph/news/articles/1068630 (archived).

[hudsonespie]

The Hidden World of the LCL Consolidation Market - Part 1

The practice of consolidation through less than container load (LCL) shipping of cargo - which involves multiple shippers and consignees in a single shipping container - has allowed thousands of shippers to move their cargo at economical prices when they cannot fill an entire full container load (FCL) solely by themselves. The global LCL market is dominated by 4 global players, also known as co-loaders or consolidators. They are Vanguard Logistics, Shipco, ECU Worldwide and CWT Globelink. The bulk of their customer base comes from the overflow volumes cascaded down from the top 50 global forwarders, and the rest comes from local forwarders. They are considered ‘neutral’ due to the notion that they support the cargo of multiple forwarder competitors in the same consolidation boxes, and they do not go after the retail shipper market and undermine their forwarder clients.

To get a sense of the scale of the volumes they can get from the bigger forwarders, the top five global forwarders each move more than two million cubic meters annually, of which roughly 25 percent cascades down to the consolidators. That is massive volume, but there are good reasons why global forwarders rely on consolidators.

Firstly, dangerous goods cargos (DG) require higher levels of compliance and regulation in terms of trucking and freight movement, warehouse storage and customs documentation. This complexity cannot be managed at scale so easily due to Material Safety Data Sheet (MSDS) checks. There are also fixed surcharges implemented at destination ports for containers with DG cargo. It therefore makes sense to co-load such cargo with a consolidator who has the specific expertise to handle it and split the surcharges across more shipments.

Secondly, some far-flung ports such as those in the Pacific island nations, South America, Africa and the Caribbean have relatively low demand, and to make it profitable enough to run a regular consolidation service would require stable and regular amounts of cargo. The alternative to this is to run an inducement service (demand-pushed) where a cargo can sit at the container freight station for weeks and it only moves out when the container is full or it becomes profitable enough to do so. This is not something most customers can accept due to unpredictable and long waiting times. Consolidators can fill this niche effectively as they can collect cargo from multiple forwarders and build a consolidation box service that is also regular to these places.

Thirdly, the big forwarders mainly run ‘gateway’ models where they route cargo from the region into a major port hub and then re-export the cargo out to the final destination. An example of this is how shipments going out from Bangkok to Jakarta are usually transhipped via Singapore for re-export into Jakarta. However, that forwarder may not be able to either run a regular service from Bangkok to Singapore for the 1st leg of the journey and may therefore co-load with a consolidator who will then deliver it to their container-freight station (CFS) in Singapore where they then handle the 2nd leg or if the consolidator can offer that direct service from Bangkok to Jakarta, the forwarder has the option of using that as well.

Low FCL rates are generally detrimental to the LCL business because margins are shaved off or business is converted to FCL otherwise. A high FCL base rate mean higher margins for LCL, and this has made the long-haul lanes - Europe-Asia, Transpacific (US West and East Coasts-Asia) and Asia-Latin America - into some of the most lucrative segments of the business for consolidators.

Over the last 10 years, due to the overcapacity of boxes in the global market, the Asia Pacific has seen much growth - especially the Intra-Asia region, which has some of the most competitive markets in the world. Here, freight costs for a 20GP container from Singapore to Hong Kong dipped to $5 per container territory in 2016. Rates have moved upwards since and hover around the $100 to $200 region, and with the exception of industry-related surcharges (VGM, AMS, AFR and BAF, GRIs, IMO 2020) have remained relatively stable.

However, the relatively low rates mean that it is hard to profit from consolidating loads, and one of the most profitable ways to make a margin from an LCL shipment in this region is to stack the margin at the destination port. The way some forwarders do this - and what some would consider opaque - is to offer negative freight rates at the origin port to the shipper. The forwarder actually rebates the shipper for shipping with them instead of accepting payment, then collects the amount back from their destination office whom in turn collects it from the consignee. Thus, the market pricing ends up with very lopsided charges and overwhelming costs back-loaded in destination markets.

Some destination markets like South Korea, Japan, Taiwan and Singapore are highly transparent, and consignees there are very well-informed of prevailing market rates - as opposed to the wild west of Southeast Asian markets (Philippines, Indonesia, Vietnam, Cambodia, Myanmar), where a mix of confusing customs regulations and laundry list of line charges continue to befuddle consignees or shippers. The best way for shippers to manage this is through requesting all-in charges or a breakdown of origin, freight and destination charges from the very beginning and indeed most global forwarders today do that.

Luke Robert consults for SME and MNC clients in navigating trade tariff agreements and advising on industry-wide regulation and the impact of political and economic trends on their supply chains. He is currently with one of the largest logistics MNC’s in the world. The views expressed here are entirely his own. 

from Storage Containers https://maritime-executive.com/article/the-hidden-world-of-the-lcl-consolidation-market-part-1 via http://www.rssmix.com/

[shristipbi]

Veterinary Intravenous Solutions Market Research Report, Share, and Forecast to 2025

Precision Business Insights (PBI) in its report titled “Global Veterinary Intravenous Solutions Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024” assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

 The global veterinary intravenous solutions market was valued at US$ XX Mn in 2018 and increasing at a significant CAGR over the forecast timeframe owing to surge in the incidence of animal rearing. Rise in the interest towards pets, increasing demand for companion animals, improved long life of pet animals due to advanced diagnostics, increase in need for improved nutrition for animal are expected to enhance the sales of the veterinary intravenous solutions market. However not having much awareness regarding the uses of veterinary intravenous solutions and high cost of the products are expected to limit the growth of the market.

 Global veterinary intravenous solutions market segmented on the basis of product type, end user, and region

 For request sample : https://www.precisionbusinessinsights.com/request-sample?product_id=37345

  Total Parenteral Nutrition Dominates the Global Veterinary Intravenous Solutions Market

Based on product type, global veterinary intravenous solutions market segmented into synthetic colloids, isotonic crystalloids, blood products, total parenteral nutrition, dextrose solutions, and partial parenteral nutrition. Among them, total parenteral nutrition products dominated the global veterinary intravenous solutions market in 2018 and estimated to dominate over the forecast period owing to increase in awareness regarding the nutritional requirements of the animals, increased care towards animals are surge the market over the forecast years.

North America Leads the Global Veterinary Intravenous Solutions Market

 PBI’s global veterinary intravenous solutions market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2013-2017 and expected to dominate over 2018-2024 owing to increasing number of pets in the houses, availability of advanced veterinary health care, rise in interest towards the disease prevention for the animals and limited natural source to feed the animals in the region are expected to increase the growth of the market over the forecasted years. Moreover, the enhanced applications of veterinary intravenous solutions in meat market for storage of meat is expected to drive the growth of the market. Asia Pacific region are expected to grow at a significant growth rate over the forecast years due to increase in cattle rearing due to increase in demand for the milk and wool, government initiatives to rear cattle, government subsidies for animal rearing and the trend of owing pets.

 Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

 Global veterinary intravenous solutions market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.

 Key player’s profiles in the report are

·         Aspen Vet

·         Merck & Co., Inc. (MSD Veterinary Manual)

·         Dechra Veterinary Products

·         Pfizer, Inc.

·         Sypharma

·         Animal Care Products. Inc.,

·         Zoetis, Inc.

 Detailed Segmentation

 By Product type

o     Synthetic colloids

o     Isotonic crystalloids

o     Blood products

o     Total parenteral nutrition

o     Dextrose solutions

o     Partial parenteral nutrition

 By End User  

o     Veterinary Hospitals

o     Research Institutes

o     Others

 Geography

o     North America

·         U.S

·         Canada

o     Europe

·         Germany

·         France

·         U.K

·         Italy

·         Spain

·         Russia

·         Poland

·         Rest of Europe

o     Asia-Pacific

·         Japan

·         China

·         India

·         Australia & New Zealand

·         ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)

·         South Korea

·         Rest of Asia-Pacific

o     Latin America

·         Brazil

·         Mexico

·         Argentina

·         Venezuela

·         Rest of Latin America

o     Middle East and Africa (MEA)

·         Gulf Cooperation Council (GCC) Countries

·         Israel

·         South Africa

·         Rest of MEA

  For more information: https://www.precisionbusinessinsights.com/market-reports/veterinary-intravenous-solutions-market/

  Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

 Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[saigonbay]

Gửi chuyển phát nhanh đi Phillipines giá rẻ, tiết kiêm

Gửi chuyển phát nhanh đi Phillipines giá rẻ, tiết kiêm

Gửi chuyển phát nhanh đi Phillipines giá rẻ, tiết kiêm

Chuyển phát nhanh quốc tế SgbExpress là nhà cung cấp dịch vụ chuyển phát nhanh, gửi hàng đi nước ngoài uy tín – chất lượng hàng đầu Việt Nam.  SgbExpress cung cấp Gửi chuyển phát nhanh đi Phillipines với dịch vụ tốt nhất của SgbExpress, FEDEX, UPS, TNT…đặc biệt dịch vụ Chuyển phát nhanh đi Philippines với cước phí vận chuyển tiết kiệm từ 30 – 50% cho mọi khách hàng.

Khi sử dụng dịch vụ Gui hang di Philippines của SgbExpress, quý khách hàng hoàn được nhiều ưu đãi và sự phục vụ tốt nhất của đội ngũ nhân viên nhiều kinh nghiệm nhiều năm trong lĩnh vực Chuyển Phát Nhanh Quốc Tế, tác phong làm việc  chuyên nghiệp và sẳn sàng tư vấn cho khách hàng 24/24. Dịch vụ Chuyen phat nhanh di Philippines nhanh chóng, tiện lợi  luôn mang lại sự hài lòng cho Quý khách hàng kể cả khách hàng khó tính nhất. Chúng tôi luôn biết cách làm thế nào để hàng hóa đến tay người nhận an toàn và nhanh chóng với cước phí tiết kiệm nhất.

Chuyển phát hàng hóa, gửi hàng nhanh đi Phillipines

Gửi chuyển phát nhanh đi Phillipines SgbExpress cam kết giao hàng tất cả các tỉnh thành của Philippines:

– QuZon,  Manila,  Caloocan, Davao, Cebu, Zamboanga, Pasig, Valenzuela, Antipolo, Taguig, Cagayan de Oro …

Vận Chuyển Hàng Hóa Đến Philippines

Khi bạn gửi đến Philippines, có một số hàng hóa bị hạn chế hoặc yêu cầu thuế vụ, bao gồm: Động vật bao gồm cả cá, Cây, Dược phẩm, Thiết bị viễn thông, máy photocopy màu,phụ tùng xe

Các mặt hàng cấm từ hàng Vận chuyển đến Philippines

Hàng cấm gửi đi Philippines

Nếu bạn đang vận chuyển hàng hóa đến Philippines, điều quan trọng là cần lưu ý rằng một số các mặt hàng đều bị cấm. Bao gồm các: Phim ảnh khiêu dâm Một số loại thuốc Súng đồ chơi mà nhìn thực tế Súng và đạn Ma túy, thuốc phiện và bất kỳ vật dụng liên quan đến việc hút thuốc phiện tiền giả Trang thiết bị hoặc máy móc cho cờ bạc

Thời gian chuyển phát nhanh đi philippines

– Thời gian lấy hàng tại Tp.HCM và Hà Nội trước 17h30 ( muộn hơn thông báo trước ).

– Thời gian các tỉnh trước 15h30 : Bình Dương, Đồng Nai, Long An….

– Thời gian chuyển hàng đi Philippines : 1-3 ngày ( tùy theo khu vực gửi ).

Bảng giá gửi hàng chuyển phát nhanh đi Philippines

– Bảng giá gửi hàng bình thường : quần áo, chứng từ, ly..

– Bảng giá gửi hàng đi nhanh ( Phát trước 12h ngày hôm sau .. ).

– Bảng giá đi chậm ( tiết kiệm ) giãm 30-50%.

– Gửi hàng yêu cầu chứng từ kèm theo: Hàng nông sản, chất Lỏng, Chất Bột, Hàng Thực Phẩm, Chất Dễ Cháy Nổ, Hàng Thuốc,…

 – Hàng Thông Thường đi Phillipines

( Quần áo, Đồ Gia Dụng, ..) Hàng thực phẩm, nông sản…. ( nên mua siêu thị, có nhãn mác;) + Hải sản khô: mực, cá, tôm, cua.. + Bánh tráng, cơm cháy, mì gói, miếng, cháo, + Gia Vị: nước tương, tương ớt, hành phi, sa tế, nước mắm, mắm tôm (Chú ý: ớt, tỏi, đường, bột ngọt, bột, không nên gửi) + Nông Sản: cafe hạt, nông sản sơ chế( rang), trà, Mít sấy, + ( Chú ý: hạt sống nẩy mầm không đi được, măng khô ) + Thuốc tây, Thuốc bắc,: dạng gel bôi, thuốc trong hộp ( Tránh: dạng bột, nước lỏng, thuốc phá thai, có thành phần nguy hại…)

– Hàng Đặt Biệt đi Phillipines

Hỗ trợ làm giấy FDA, MSDS, Hun Trùng, Đóng kiện gỗ ( Khoáng chất, Chất lỏng, Chất Bột, Than, Gỗ, Hóa Chất, Dược Phẩm, Nước Uống …)

– Hàng có giá trị đi Phillipines

Yến sào, Quà Tặng Chú ý không nhận gửi Hàng điện tử (có Pin, Từ Trường : điện thoại, laptop, máy ảnh, loa, micro, taiphone ..)

Gửi hàng đi Philippines – Dịch vụ tiện lợi và tiết kiệm nhất của SgbExpress.

– Chi phí vận chuyển tiết kiệm 30-50 % so với chính hãng. – Tư vẫn dịch vụ miễm phí bởi đội ngũ nhân viên giàu kinh nghiệm nhất. – Dịch vụ chuyển phát nhanh Door -to – Door: giao nhận hàng tận nơi nhanh chóng – Đóng gói hàng hóa miễn phí – MIễn phí dịch vụ làm hải quan cho khách hàng – Hưởng dịch vụ khuyến mãi giá cước nhiều tuyến trên thế giới hàng tháng.

Quý khách đang muốn tìm công ty chuyển phát nhanh đi Philippines và từ Philippines về Việt Nam hàng hóa, tài liệu…., gửi hàng từ Việt Nam sang Philippines ? Quý khách đang tìm dịch vụ chuyển hàng từ Việt Nam đi Philippines và từ Philippines về Việt Nam giá rẻ tại TP HCM và Hà Nội? Hãy đến với công ty chuyển phát nhanh quốc tế hàng đầu tại Việt Nam của chúng tôi. Với các dịch vụ : Gửi hàng đi Philippines , nhập hàng từ Philippines về Việt Nam, công ty chuyển phát nhanh đi Philippines giá rẻ, dịch vụ gửi hàng hóa đi Philippines uy tín, đảm bảo nhất. Xuất khẩu hàng hóa đi nước Philippines nhanh chóng và giá rẻ.

Vận chuyển hàng đi Philippines ,Nhập hàng từ Philippines về Việt Nam, chuyển phát nhanh hàng hóa qua Philippines giá rẻ nhất, gửi hàng sang Philippines đảm bảo uy tín tại TP HCM và Hà Nội

Nền kinh tế quốc gia của Philippines lớn thứ 41 thế giới, theo ước tính, GDP danh nghĩa vào năm 2013 là 272.207 triệu đô la Mỹ. Các mặt hàng xuất khẩu chính của Philippines bao gồm các sản phẩm bán dẫn và điện tử, thiết bị vận tải, hàng may mặc, các sản phẩm đồng, các sản phẩm dầu mỏ, dầu dừa, và quả.Các đối tác thương mại lớn của Philippines bao gồm Hoa Kỳ, Nhật Bản, Trung Quốc, Singapore, Hàn Quốc, Hà Lan, Hong Kong, Đức, Đài Loan và Thái Lan. Philippines là một quốc gia công nghiệp mới, nền kinh tế đang trong quá trình chuyển đổi từ dựa vào nông nghiệp sang dựa vào các ngành dịch vụ và chế tạo. Tổng lực lượng lao động trên toàn quốc là khoảng 38,1 triệu,lĩnh vực nông nghiệp sử dụng gần 32% lực lượng lao động song chỉ đóng góp 14% GDP. Lĩnh vực công nghiệp thu hút gần 14% lực lượng lao động và đóng góp 30% GDP. 47% lực lượng lao động tham gia vào lĩnh vực dịch vụ và đóng góp 56% GDP

Tại sao bạn nên chọn dịch vụ chuyển phát nhanh quốc tế đi Phillipines của SgbExpress

Với nhiều năm kinh nghiệm trong nghề chuyển phát nhanh quốc tế SgbExpress tự tin mang đến cho bạn dịch vụ uy tín chất lượng với giá vô cùng ưu đãi. –     Miễn phí đóng hàng, nhận hàng hóa và giao hàng chính xác tận nơi –    Có nhiều gói cước linh động để khách hàng lựa chọn, phụ thuộc vào thời gian, địa điểm giao hàng. –    Chuyển đến hơn 200 nước trên thế giới trong 2-5 ngày làm việc. –    Có thể chuyển phát nhanh đến vùng nông thôn, vùng sâu vùng xa trên thới giới. –    Có thể chuyển phát nhanh hẹn giờ ( giao đúng ngày hẹn) theo yêu cầu của khách hàng. –    Giá và dịch vụ : Rất linh động như dịch vụ Door To Door  hoặc Air Port To Air Port… –    Dịch vu đi nhanh :  Hàng cần gấp –    Dịch vụ đi chậm   : Hàng không gấp, đi theo dạng economy tiết kiệm chi phí –    Hơn thế nữa, những lô hàng nặng trên 21 kg thì công ty luôn đưa ra giá NET để tiết kiệm chi phí rẻ hơn hàng sea –    Khi gửi thực phẩm đi nước ngoài kiện hàng trên 10 kg sẽ được miễn phí đăng ký FDA –    Nếu khách hàng là cá nhân chúng tôi sẽ giảm 10% VAT nếu bạn không lấy hóa đơn –    Luôn theo dõi hàng sát, dù chỉ là 1 lá thư nhỏ, và hỗ trợ khách hàng 24/24 –    Giá cạnh tranh cho từng lô hàng nếu có thông tin cụ thể, khối lượng hàng càng lớn thì giá càng tiết kiệm. –    Hàng của bạn sẽ được gửi đến nơi nhanh chóng và an toàn. Cam kết: + Bình ổn giá và chính sách chiết khấu cao. + Đảm bảo thời gian vận chuyển và mở rộng thị trường. + Luôn mang đến sự hài lòng về dịch vụ. + Trở thành công cụ tiện ích mỗi khi Quý Khách Hàng có nhu cầu. + Tích cực lắng nghe ý kiến đóng của Quý Khách Hàng. + Nâng cao chất lượng dịch vụ, hỗ trợ dịch vụ miễn phí có liên quan.

Chuyển phát nhanh đi Philippines giá rẻ tại TP HCM và Hà Nội

Hiện nay công ty chúng tôi đang được rất nhiều khách hàng tin dùng và được đánh giá cao về chất lượng dịch vụ và giá cả hợp lý nhất. Chuyển phát nhanh đi Philippines của công ty chúng tôi luôn bảo đảm giao hàng nhanh nhất, rẻ nhất, an toàn và hiệu quả nhất.

Chuyển phát nhanh đi Philippines  tại các tỉnh:

Gửi đồ qua Philippines tại: Tp HCM Gửi hàng đi Philippines : Hà Nội Bình Dương Hải Phòng Cần Thơ Huế Bắc Giang Nha Trang Khánh Hòa Thái Bình Nghệ An, Hà Tĩnh Đồng Nai Bắc Ninh Đà Nẵng Nha Trang Nam Định Ninh Bình Hội An, Quảng Nam Quảng Ngãi Quảng Ninh

Hãy liên hệ với chúng tôi để được hỗ trợ giá cước tốt nhất và tư vấn dịch vụ đầy đủ nhất. SgbExpress sẽ là cầu nối giúp bạn gửi hàng nhanh chóng và tiết kiệm ra nước ngoài.

Xem bài viết gốc tại : Gửi chuyển phát nhanh đi Phillipines giá rẻ, tiết kiêm

https://sgbexpress.com

[srmprpickups]

[cherylrhutcherson]

Global Medication Market - Overview and Regional Outlook Study 2018-2025

This report studies the global market size of Medication in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Medication in these regions.

Request a Sample of this Report@ https://www.orbisresearch.com/contacts/request-sample/2305721

This research report categorizes the global Medication market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.

In 2017, the global Medication market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Medication market based on company, product type, application and key regions.

The various contributors involved in the value chain of Medication include manufacturers, suppliers, distributors, intermediaries, and customers.

The key manufacturers in the Medication include

Pfizer

Roche

Sanofi

Johnson & Johnson

Merck & Co. (MSD)

Novartis

AbbVie

Gilead Sciences

GlaxoSmithKline (GSK)

Amgen

AstraZeneca

Bristol-Myers Squibb

Eli Lilly

Teva

Bayer

Novo Nordisk

Allergan

Shire

Boehringer Ingelheim

Takeda

Market Size Split by Type

Brand Drugs

Generic Drug

Market Size Split by Application

Hospital

Clinic

Other

Market size split by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

To make an enquiry on report@ https://www.orbisresearch.com/contacts/enquiry-before-buying/2305721

Some Point from Table of Content:

Chapter One: Study Coverage

1.1 Medication Product

1.2 Key Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Medication Market Size Growth Rate by Type

1.4.2 Brand Drugs

1.4.3 Generic Drug

1.5 Market by Application

1.5.1 Global Medication Market Size Growth Rate by Application

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Other

1.6 Study Objectives

1.7 Years Considered

Chapter Two: Executive Summary

2.1 Global Medication Market Size

2.1.1 Global Medication Revenue 2016-2025

2.1.2 Global Medication Sales 2016-2025

2.2 Medication Growth Rate by Regions

2.2.1 Global Medication Sales by Regions

2.2.2 Global Medication Revenue by Regions

Browse full report@ https://www.orbisresearch.com/reports/index/global-medication-market-insights-forecast-to-2025

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No: +1 (214) 884-6817; +912064101019

Email ID: sales@orbisresearch.com